Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-22-034577

Chief Financial Officer acquired 42,500 shares (grant or award)

  • Chief Financial Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Arkowitz David · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2022-06-15 Exercise or conversion : show line 1 in the form +5,000 70,492 D
2022-10-27 Grant or award : show line 2 in the form +42,500 112,992 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-15 Exercise or conversion : show line 3 in the form Restricted Stock Units −5,000 0 D
Loading xslF345X03/doc4.xml…